Cargando…
Neoadjuvant immunotherapy in resectable head and neck cancer: oral cavity carcinoma as a potential research model
Squamous cell carcinoma of oral cavity (OCSCC) accounts for approximately 25% of cases of head and neck squamous cell carcinoma (HNSCC). Tobacco and alcohol consumption are the main risk factors for both cancers. Surgical resection, combined with adjuvant radiotherapy or radiochemotherapy in patient...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905482/ https://www.ncbi.nlm.nih.gov/pubmed/33747147 http://dx.doi.org/10.1177/1758835920984061 |